Literature DB >> 9018050

Mapping of antigenic sites involved in neutralization on the capsid protein of feline calicivirus.

Y Tohya1, N Yokoyama, K Maeda, Y Kawaguchi, T Mikami.   

Abstract

In order to locate amino acid residues involved in the formation of feline calicivirus (FCV) neutralizing epitopes, we analysed the capsid protein gene of monoclonal antibody neutralization-resistant variants of FCV. Amino acid substitutions in the variants were identified in the two hypervariable regions of the capsid protein. Four linear and two conformational epitopes were located in the regions from residues 426 to 460 and 490 to 520, respectively. The relative positions of individual epitopes agreed with our previous antigenic analysis. Two antigenic sites composed of the neutralizing epitopes were mapped in the hypervariable regions of the capsid protein, demonstrating that a relationship exists between the genetic variability and antigenic differences in the neutralization of FCV.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9018050     DOI: 10.1099/0022-1317-78-2-303

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  24 in total

1.  Evolutionary mechanisms of persistence and diversification of a calicivirus within endemically infected natural host populations.

Authors:  Karen P Coyne; Rosalind M Gaskell; Susan Dawson; Carol J Porter; Alan D Radford
Journal:  J Virol       Date:  2006-12-06       Impact factor: 5.103

2.  Genogrouping of vaccine breakdown strains (VBS) of feline calicivirus in Japan.

Authors:  K Ohe; S Sakai; T Takahasi; F Sunaga; M Murakami; A Kiuchi; M Fukuyama; K Furuhata; M Hara; Y Ishikawa; A Taneno
Journal:  Vet Res Commun       Date:  2007-05       Impact factor: 2.459

3.  FCV-VBS isolated from cats with typical symptoms caused VSD in experimental cats.

Authors:  Kyoko Ohe; Toshikazu Takahashi; Daisuke Hara; Motonobu Hara
Journal:  Vet Res Commun       Date:  2007-09-25       Impact factor: 2.459

4.  Characterization of a broadly reactive monoclonal antibody against norovirus genogroups I and II: recognition of a novel conformational epitope.

Authors:  Tomoyuki Shiota; Michio Okame; Sayaka Takanashi; Pattara Khamrin; Makiko Takagi; Kenji Satou; Yuichi Masuoka; Fumihiro Yagyu; Yuko Shimizu; Hideki Kohno; Masashi Mizuguchi; Shoko Okitsu; Hiroshi Ushijima
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

5.  Conformational changes in the capsid of a calicivirus upon interaction with its functional receptor.

Authors:  Robert J Ossiboff; Yi Zhou; Patrick J Lightfoot; B V Venkataram Prasad; John S L Parker
Journal:  J Virol       Date:  2010-03-31       Impact factor: 5.103

6.  Recovery and altered neutralization specificities of chimeric viruses containing capsid protein domain exchanges from antigenically distinct strains of feline calicivirus.

Authors:  J D Neill; S V Sosnovtsev; K Y Green
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

7.  Capsid protein gene variation among feline calicivirus isolates.

Authors:  T Horimoto; Y Takeda; K Iwatsuki-Horimoto; S Sugii; T Tajima
Journal:  Virus Genes       Date:  2001       Impact factor: 2.332

8.  Genetic characterization of feline calicivirus strains associated with varying disease manifestations during an outbreak season in Missouri (1995-1996).

Authors:  Victor G Prikhodko; Carlos Sandoval-Jaime; Eugenio J Abente; Karin Bok; Gabriel I Parra; Igor B Rogozin; Eileen N Ostlund; Kim Y Green; Stanislav V Sosnovtsev
Journal:  Virus Genes       Date:  2013-11-12       Impact factor: 2.332

9.  Presence of a surface-exposed loop facilitates trypsinization of particles of Sinsiro virus, a genogroup II.3 norovirus.

Authors:  Shantanu Kumar; Wendy Ochoa; Shinichi Kobayashi; Vijay S Reddy
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

10.  High genetic diversity of the immunodominant region of the feline calicivirus capsid gene in endemically infected cat colonies.

Authors:  Alan D Radford; Susan Dawson; Ruth Ryvar; Karen Coyne; Deborah R Johnson; Michael B Cox; Els F J Acke; Diane D Addie; Rosalind M Gaskell
Journal:  Virus Genes       Date:  2003-10       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.